These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 16185944

  • 1. Relative binding affinities of bisphosphonates for human bone and relationship to antiresorptive efficacy.
    Leu CT, Luegmayr E, Freedman LP, Rodan GA, Reszka AA.
    Bone; 2006 May; 38(5):628-36. PubMed ID: 16185944
    [Abstract] [Full Text] [Related]

  • 2. Bisphosphonates: the first 40 years.
    Russell RG.
    Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003
    [Abstract] [Full Text] [Related]

  • 3. The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase.
    David P, Nguyen H, Barbier A, Baron R.
    J Bone Miner Res; 1996 Oct; 11(10):1498-507. PubMed ID: 8889850
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.
    Russell RG, Xia Z, Dunford JE, Oppermann U, Kwaasi A, Hulley PA, Kavanagh KL, Triffitt JT, Lundy MW, Phipps RJ, Barnett BL, Coxon FP, Rogers MJ, Watts NB, Ebetino FH.
    Ann N Y Acad Sci; 2007 Nov; 1117():209-57. PubMed ID: 18056045
    [Abstract] [Full Text] [Related]

  • 6. Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells.
    Coxon FP, Thompson K, Roelofs AJ, Ebetino FH, Rogers MJ.
    Bone; 2008 May; 42(5):848-60. PubMed ID: 18325866
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition of inflammatory and bone-resorption-inhibitory effects of alendronate by etidronate.
    Funayama H, Ohsako M, Monma Y, Mayanagi H, Sugawara S, Endo Y.
    Calcif Tissue Int; 2005 Jun; 76(6):448-57. PubMed ID: 15895282
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Physiology of the aging bone and mechanisms of action of bisphosphonates.
    Dominguez LJ, Di Bella G, Belvedere M, Barbagallo M.
    Biogerontology; 2011 Oct; 12(5):397-408. PubMed ID: 21695491
    [Abstract] [Full Text] [Related]

  • 13. Bone-specific alkaline phosphatase activity is inhibited by bisphosphonates: role of divalent cations.
    Vaisman DN, McCarthy AD, Cortizo AM.
    Biol Trace Elem Res; 2005 May; 104(2):131-40. PubMed ID: 15894813
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase.
    Stresing V, Fournier PG, Bellahcène A, Benzaïd I, Mönkkönen H, Colombel M, Ebetino FH, Castronovo V, Clézardin P.
    Bone; 2011 Feb; 48(2):259-66. PubMed ID: 20920623
    [Abstract] [Full Text] [Related]

  • 16. Bisphosphonates: Pharmacokinetics, bioavailability, mechanisms of action, clinical applications in children, and effects on tooth development.
    Soares AP, do Espírito Santo RF, Line SR, Pinto Md, Santos Pde M, Toralles MB, do Espírito Santo AR.
    Environ Toxicol Pharmacol; 2016 Mar; 42():212-7. PubMed ID: 26895384
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.
    Russell RG, Watts NB, Ebetino FH, Rogers MJ.
    Osteoporos Int; 2008 Jun; 19(6):733-59. PubMed ID: 18214569
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inflammatory Effects of Nitrogen-Containing Bisphosphonates (N-BPs): Modulation by Non-N-BPs.
    Shima K, Tsuchiya M, Oizumi T, Takano-Yamamoto T, Sugawara S, Endo Y.
    Biol Pharm Bull; 2017 Jun; 40(1):25-33. PubMed ID: 28049945
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.